
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Huge Iranian missile fragments, intercepted by air defenses, lay scattered across Israel, West Bank - 2
Takeaways from AP’s report on potential impacts of Alaska’s proposed Ambler Access Road - 3
Young Muslims in Germany feel left out of Mideast debate, experts say - 4
Most loved Public Dish: Which One Addresses Its Nation Best? - 5
What will the Artemis 2 astronauts eat during their historic moon mission? (video)
Step by step instructions to Look at Compact disc Rates: A Thorough Aide
From a new flagship space telescope to lunar exploration, global cooperation – and competition – will make 2026 an exciting year for space
A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
$30K Disability Scam Implodes After Surf Trip in Mexico
I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
White House responds to Sabrina Carpenter after pop star slams 'evil' ICE video using her song
A new mom skipped a routine appointment. An infected cut led to a devastating diagnosis
Manual for Big name Work out schedules











